N1-(E)-(2-CHLOROPHENYL)-N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZONE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | IinS3SP2FbR |
|---|---|
| InChI | InChI=1S/C28H38ClN3O2S/c1-25-12-6-13-26(2,23(33)34)21(25)11-14-28-15-19(9-10-22(25)28)27(3,17-28)31-24(35)32-30-16-18-7-4-5-8-20(18)29/h4-5,7-8,16,19,21-22H,6,9-15,17H2,1-3H3,(H,33,34)(H2,31,32,35)/b30-16+/t19-,21+,22+,25-,26-,27-,28+/m1/s1 |
| InChIKey | GLXGRTIRIVLSSA-XRRKBNPHSA-N |
| Mol Weight | 516.1 g/mol |
| Molecular Formula | C28H38ClN3O2S |
| Exact Mass | 515.237326 g/mol |
| Enantiomer InChIKey | GLXGRTIRIVLSSA-PKGVJGBUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
N1-(E)-PHENYL-N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZONE
N1-(E)-(4-HYDROXYPHENYL)-N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZONE
N1-(E)-(4-METHYLPHENYL)-N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZONE
N1-(E)-(4-METHOXYPHENYL)-N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZONE
N1-(E)-(4-CHLOROPHENYL)-N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZONE
N1-(E)-(4-DIMETHYLAMINOPHENYL)-N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZONE
N4-(ENT-KAUREN-16-BETA-METHYL-19-OIC-ACID)-THIOSEMICARBAZIDE
ENT-16,17-DIACETOXYKAURAN-16-OIC-ACID
4-ALPHA-CARBOXY-13-ALPHA-AMINO-13,16-SECO-ENT-12-BETA-HYDROXY-19-NORBEYERAN_16-OIC_ACID-13,16-LACTAM
12-BETA-HYDROXYISOSTEVIOL;ENT-12-ALPHA-HYDROXY-16-KETOBEYERAN-19-OIC-ACID
| Title | Journal or Book | Year |
|---|---|---|
| Antitrypanosomal Activity of Novel Benzaldehyde-Thiosemicarbazone Derivatives from Kaurenoic Acid † | Molecules | 2011 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.